Pharmaceutical trademarks—Iceland—Q&A guide
Pharmaceutical trademarks—Iceland—Q&A guide

The following Life Sciences practice note provides comprehensive and up to date legal information covering:

  • Pharmaceutical trademarks—Iceland—Q&A guide
  • 1. What is the primary law governing trademarks in your jurisdiction?
  • 2. Which agency is responsible for the grant and registration of pharmaceutical trademarks?
  • 3. What are the relevant national and international regulatory bodies and requirements that need to be considered when clearing a pharmaceutical trademark?
  • 4. What non-traditional trademarks are available in your jurisdiction and how are they registered?
  • 5. Does your jurisdiction allow the registration of cannabis-derived products?
  • 6. What are the rules governing parallel imports of pharmaceutical goods?
  • 7. What strategies are available to police and enforce against parallel imports?
  • 8. What types of legal or administrative proceedings are available to enforce against infringing products?
  • 9. What are the available remedies for infringement?
  • More...

This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Iceland published as part of the Lexology Getting the Deal Through series by Law Business Research (published: February 2021).

Authors: GH Sigurgeirsson Intellectual Property—Hulda Árnadóttir; María Kristjánsdóttir

1. What is the primary law governing trademarks in your jurisdiction?

The primary law governing trademarks in Iceland is the Trademark Act No. 45/1997 (the Trademark Act). On 1 September 2020, amendments to the Trademark Act came into force. The amendments implement the European Union trademark directive 2015/2436 into Icelandic law. The Act contains various new provisions and harmonises the EU and European Economic Area (the EEA) trademark systems, not only regarding trademarks but also collective marks and guarantee and certification marks.

Iceland is a part of the EEA and therefore the Trademark Act is largely in line with EU trademark law and both the Icelandic Intellectual Property Office (the ISIPO) and the Appeals Committee frequently refer to the practice of the EUIPO and the EU courts in their decisions.

2. Which agency is responsible for the grant and registration of pharmaceutical trademarks?

The ISIPO is responsible for the grant and registration of pharmaceutical trademarks in Iceland.

3. What are the relevant national and international regulatory bodies and requirements that need to be considered when clearing a pharmaceutical trademark?

Like all trademarks, pharmaceutical trademarks must meet the requirements set forth in the Trademark Act

Popular documents